Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry

Here we analyze hospitalized andintensive care unit coronavirus disease 2019 (COVID‐19) patient outcomes from the international VIRUS registry (https://clinicaltrials.gov/ct2/show/NCT04323787). We find that COVID‐19 patients administered unfractionated heparin but not enoxaparin have a higher mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkup, Christian, Pawlowski, Colin, Puranik, Arjun, Conrad, Ian, O'Horo, John C., Gomaa, Dina, Banner‐Goodspeed, Valerie M, Mosier, Jarrod M, Zabolotskikh, Igor Borisovich, Daugherty, Steven K., Bernstein, Michael A., Zaren, Howard A., Bansal, Vikas, Pickering, Brian, Badley, Andrew D., Kashyap, Rahul, Venkatakrishnan, A. J., Soundararajan, Venky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013987/
https://www.ncbi.nlm.nih.gov/pubmed/33666246
http://dx.doi.org/10.1002/jmv.26918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013987/
https://www.ncbi.nlm.nih.gov/pubmed/33666246
http://dx.doi.org/10.1002/jmv.26918

Ejemplares similares